Literature DB >> 10226887

T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes.

D Dubois-LaForgue1, J C Carel, P F Bougnères, J G Guillet, C Boitard.   

Abstract

Insulin-dependent diabetes mellitus (IDDM) results from the selective destruction of pancreatic beta cells by a T cell-mediated autoimmune process. Insulin and proinsulin are the only known beta cell-specific autoantigens. Using short-term cultures of freshly isolated peripheral blood mononuclear cells, we evaluated T-cell responses to proinsulin and to insulin in IDDM patients and individuals at risk for IDDM. A proliferative T-cell response to proinsulin was observed in only 2 of 26 recent-onset IDDM subjects and 2 of 12 long-standing IDDM subjects and was associated with a proliferative response to insulin. In contrast, 5 of 13 islet cell autoantibody-positive first-degree relatives of IDDM patients showed a proliferative response to proinsulin alone, 3 of 13 to insulin alone, and 1 of 13 to both insulin and proinsulin. Overall, 9 of 13 ICA-positive first-degree relatives responded to either proinsulin or insulin. We observed an inverse relationship between antiinsulin antibodies and T-cell responses to insulin in ICA-positive first-degree relatives but not in long-standing IDDM patients. Our data indicate that proinsulin is a major antigen in IDDM and, further, illustrate the difference between the autoimmune response to insulin and the immune response to exogenous insulin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226887     DOI: 10.1023/a:1020558601175

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  50 in total

1.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.

Authors:  M Del Val; H J Schlicht; T Ruppert; M J Reddehase; U H Koszinowski
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

Review 2.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors:  L Castaño; G S Eisenbarth
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  The relationship between humoral and cellular immunity to IA-2 in IDDM.

Authors:  T M Ellis; D A Schatz; E W Ottendorfer; M S Lan; C Wasserfall; P J Salisbury; J X She; A L Notkins; N K Maclaren; M A Atkinson
Journal:  Diabetes       Date:  1998-04       Impact factor: 9.461

4.  Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes.

Authors:  A G Ziegler; R Ziegler; P Vardi; R A Jackson; J S Soeldner; G S Eisenbarth
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

5.  Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs.

Authors:  E Kawasaki; L Yu; R Gianani; C F Verge; S Babu; E Bonifacio; G S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

6.  Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.

Authors:  G Rudy; N Stone; L C Harrison; P G Colman; P McNair; V Brusic; M B French; M C Honeyman; B Tait; A M Lew
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

7.  Evidence for the effects of a superantigen in rheumatoid arthritis.

Authors:  X Paliard; S G West; J A Lafferty; J R Clements; J W Kappler; P Marrack; B L Kotzin
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

8.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

Authors:  S Caillat-Zucman; H J Garchon; J Timsit; R Assan; C Boitard; I Djilali-Saiah; P Bougnères; J F Bach
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

10.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  8 in total

1.  Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.

Authors:  Andréa Toma; Samy Haddouk; Jean-Paul Briand; Luc Camoin; Hanne Gahery; Francine Connan; Danielle Dubois-Laforgue; Sophie Caillat-Zucman; Jean-Gérard Guillet; Jean-Claude Carel; Sylviane Muller; Jeannine Choppin; Christian Boitard
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-19       Impact factor: 11.205

2.  Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.

Authors:  Michelle So; Colleen M Elso; Eleonora Tresoldi; Miha Pakusch; Vimukthi Pathiraja; John M Wentworth; Leonard C Harrison; Balasubramanian Krishnamurthy; Helen E Thomas; Christine Rodda; Fergus J Cameron; Jacinta McMahon; Thomas W H Kay; Stuart I Mannering
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

3.  Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.

Authors:  Peter Achenbach; Kerstin Koczwara; Annette Knopff; Heike Naserke; Anette-G Ziegler; Ezio Bonifacio
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

4.  A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin.

Authors:  D G Alleva; P D Crowe; L Jin; W W Kwok; N Ling; M Gottschalk; P J Conlon; P A Gottlieb; A L Putnam; A Gaur
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.

Authors:  Karine Thébault-Baumont; Danielle Dubois-Laforgue; Patricia Krief; Jean-Paul Briand; Philippe Halbout; Karine Vallon-Geoffroy; Joëlle Morin; Véronique Laloux; Agnès Lehuen; Jean-Claude Carel; Jacques Jami; Sylviane Muller; Christian Boitard
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 6.  T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.

Authors:  Roberto Mallone; Vedran Brezar; Christian Boitard
Journal:  Clin Dev Immunol       Date:  2011-07-19

7.  Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes.

Authors:  Andréa Toma; Taghrid Laïka; Samy Haddouk; Sandrine Luce; Jean-Paul Briand; Luc Camoin; Francine Connan; Marion Lambert; Sophie Caillat-Zucman; Jean-Claude Carel; Sylviane Muller; Jeannine Choppin; François Lemonnier; Christian Boitard
Journal:  Diabetes       Date:  2008-11-14       Impact factor: 9.461

Review 8.  The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes.

Authors:  Leonard C Harrison
Journal:  Mol Metab       Date:  2021-07-07       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.